Clinical Education InitiativeMenu
Search
Home > Courses > Opioid Dependency, HCV and HCV/HIV Coinfection

Opioid Dependency, HCV and HCV/HIV Coinfection

Opioid Dependency, HCV and HCV/HIV Coinfection
Opioid Dependency, HCV and HCV/HIV Coinfection
Play
Sorry, this learning module is not available for mobile devices.
Resource ID: CM439
Original Presentation: 12/13/2016
Web Posting: 3/20/2017
CE Expiration: 12/12/2019
Presenter
  • Brianna Norton, DO, MPH
    Associate Professor
    Albert Einstein College of Medicine
Learning Objectives
At the completion of this educational session, participants will:
  1. Understand HCV treatment outcomes in persons who inject drugs.
  2. Appreciate the unique barriers and facilitators to HCV care for PWID.
  3. Know about the changing demographics of PWID with HCV.
  4. Be aware of harm reduction strategies for primary and secondary prevention of HCV.
Presenter Bio
Brianna Norton, DO, MPH
Brianna Norton is an Associate Professor of Medicine at Albert Einstein College of Medicine and the Hepatitis C Medical Director of the Comprehensive Health Care Clinic of Montefiore Medical Center. Dr. Norton is currently conducting an NIH funded study to investigate group HCV treatment in primary care for people who inject drugs. She is also the Medical Director of the New York Harm Reduction Educators, a syringe exchange operating in East Harlem and throughout the Bronx.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on December 13, 2016 and will terminate December 12, 2019.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity. 

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Dr. Brianna Norton (Presenter) had no relevant financial relationships to disclose.  Dr. Norton submitted her slides in advance for adequate peer reiew, and will support her presentation and clinical recommendations with the best available evidence from the medical literature.

Financial Support

This meeting of the Physicians' Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

Details:

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules